Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience.
Haematologica
; 107(10): 2474-2479, 2022 10 01.
Article
in En
| MEDLINE
| ID: mdl-35734931
Full text:
1
Database:
MEDLINE
Main subject:
Idarubicin
/
Leukemia, Myeloid, Acute
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2022
Type:
Article